Level C· Early human research exploring benefitsCohort StudyPubMed

A Pilot Study on the Impact of Smoking on Adipose-Derived Stem Cell Function in Burn Patients.

Deville P., Dennis J., Warren O., Fontenot C., Messa G., Carter JE.

Cohort Study on Chronic Wound, Burns, Chronic Inflammation, published in J Burn Care Res (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Cohort Study
Journal
J Burn Care Res (2025)
Country
England
Reported sample size
—
Source database
PubMed
PMID
39820680
DOI
10.1093/jbcr/iraf005

Abstract (original English)

Adipose-derived stem cells (ADSCs) have an important role in the modulation of burned tissue repair through the release of paracrine factors that stimulate the wound healing response. In this study, we tested the hypothesis that smoking status alters the profile of paracrine factors secreted from ADSCs isolated from damaged adipose tissue. Adipose tissue was collected from adult patients (N = 8) with severe burn injuries (>20% total body surface area) at the index operation. ADSCs were extracted and cultured in vitro. Supernatants were harvested 30 h after plating and used for cytokine determinations by Multiplex assay. Fluorescence-activated single-cell sorting (FACS) confirmed their phenotype with markers CD 90, CD 166, and CD 73. Univariate analyses were performed to compare the 2 cohorts (Smokers vs nonsmokers). Higher amounts of anti-inflammatory cytokines IL-4 (P = .03) and IL-10 (P = .04) and pro-inflammatory cytokines TNF-alpha (P = .03), IL-8, and IFN-gamma (P = .03) were detected in burn patients who were current everyday smokers when compared to nonsmokers, or former smokers. No significant differences in supernatant concentrations of IL-17, IL-1 beta, TGF-alpha, IL-6, and IL-13 were observed (P > .05). Mortality was higher in the smoker group when compared to nonsmokers. The results from this study suggest that smoking status in patients with a major burn injury may

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
HumansBurnsPilot ProjectsMaleFemaleAdultSmokingMiddle AgedCytokinesAdipose Tissue

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research